Literature DB >> 15015593

HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma.

W Kimryn Rathmell1, Geza Acs, M Celeste Simon, David J Vaughn.   

Abstract

Angiosarcoma is a rare and highly aggressive tumor of endothelial origin. The molecular mechanisms driving angiosarcoma growth have not been fully elucidated, although autocrine stimulation by vascular endothelial growth factor (VEGF) secretion may play a role in the pathogenesis of this tumor. We identified a patient with a very rare form of angiosarcoma arising from the retroperitoneum. Immunohistochemical analysis demonstrated widespread up-regulation of the hypoxic response pathway as a mechanism of enhanced VEGF expression. Disordered regulation of the hypoxic response pathway can result in the expression of factors such as VEGF and erythropoietin, which may promote autocrine tumor growth in angiosarcoma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15015593

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  11 in total

1.  Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.

Authors:  Jui-Han Huang; Frank S Lee; Theresa L Pasha; Mary D Sammel; Giorgos Karakousis; George Xu; Douglas Fraker; Paul J Zhang
Journal:  Cancer Biol Ther       Date:  2009-12-22       Impact factor: 4.742

Review 2.  Advances in the systemic treatment of cutaneous sarcomas.

Authors:  Jason J Luke; Mary Louise Keohan
Journal:  Semin Oncol       Date:  2012-04       Impact factor: 4.929

3.  Disseminated Hemangiosarcoma in a Juvenile Rhesus Macaque (Macaca mulatta).

Authors:  Amanda P Beck; Stanton B Gray; Beth K Chaffee
Journal:  Comp Med       Date:  2016       Impact factor: 0.982

Review 4.  Clinical and Pathologic Features of Primary Angiosarcoma of the Kidney.

Authors:  Ayo O Omiyale; James Carton
Journal:  Curr Urol Rep       Date:  2018-01-31       Impact factor: 3.092

5.  Loss of autocrine endothelial-derived VEGF significantly reduces hemangiosarcoma development in conditional p53-deficient mice.

Authors:  Morvarid Farhang Ghahremani; Enrico Radaelli; Katharina Haigh; Sonia Bartunkova; Lieven Haenebalcke; Jean-Christophe Marine; Steven Goossens; Jody J Haigh
Journal:  Cell Cycle       Date:  2014-03-11       Impact factor: 4.534

6.  Aberrations in Angiogenic Signaling and MYC Amplifications are Distinguishing Features of Angiosarcoma.

Authors:  Vittal Kurisetty; Brad A Bryan
Journal:  Angiol Open Access       Date:  2013-04-08

7.  Phospholipase C gamma 1 (PLCG1) R707Q mutation is counterselected under targeted therapy in a patient with hepatic angiosarcoma.

Authors:  Hans Prenen; Dominiek Smeets; Massimiliano Mazzone; Diether Lambrechts; Xavier Sagaert; Raf Sciot; Maria Debiec-Rychter
Journal:  Oncotarget       Date:  2015-11-03

8.  Endothelial cell malignancies: new insights from the laboratory and clinic.

Authors:  Michael J Wagner; Vinod Ravi; David G Menter; Anil K Sood
Journal:  NPJ Precis Oncol       Date:  2017-04-20

9.  High-grade angiosarcoma presenting with cytology-negative hemorrhagic ascites.

Authors:  Ankit P Patel; James L Peacock; Peter A Prieto
Journal:  J Surg Case Rep       Date:  2018-10-11

10.  The role of hypoxia in 2-butoxyethanol-induced hemangiosarcoma.

Authors:  Daphna Laifenfeld; Annalyn Gilchrist; David Drubin; Milena Jorge; Sean F Eddy; Brian P Frushour; Bill Ladd; Leslie A Obert; Mark M Gosink; Jon C Cook; Kay Criswell; Christopher J Somps; Petra Koza-Taylor; Keith O Elliston; Michael P Lawton
Journal:  Toxicol Sci       Date:  2009-10-07       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.